| Name | Title | Contact Details |
|---|---|---|
James Snook |
VP of Sales and Service | Profile |
Wilson Malo |
Chief Financial Officer | Profile |
Nura Inc is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bio-Path is a biotechnology company developing targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging cancers. The company`s lead product candidate, prexigebersen (Liposomal Grb2 Antisense), formerly BP1001, is currently being assessed in a Phase 2 clinical study in 54 people with previously untreated AML who are not eligible for or who have decided to forego intensive induction therapy because of their age or fragile health.
Discovering new medicines by combining ultra throughput biochemistry and machine learning.
Stuart Therapeutics was established in 2017 for the development and commercialization of PolyCol, a versatile therapeutic platform that offers a unique tissue reparative approach to a variety of ophthalmic disease indications.
CE & IC Inc is a Burlington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.